Risk of Parkinson's disease after tamoxifen treatment

Risk of Parkinson's disease after tamoxifen treatment

<p>Abstract</p> <p>Background</p> <p>Women have a reduced risk of developing Parkinson's disease (PD) compared with age-matched men. Neuro-protective effects of estrogen potentially explain this difference. Tamoxifen, commonly used in breast cancer treatment, may i...

Full description

Bibliographic Details
Main Authors:	Destefano Anita L, Dybdahl Merete, Latourelle Jeanne C, Myers Richard H, Lash Timothy L
Format:	Article
Language:	English
Published:	BMC 2010-04-01
Series:	BMC Neurology
Online Access:	http://www.biomedcentral.com/1471-2377/10/23

Similar Items

Genomewide association study for onset age in Parkinson disease
by: Halter Cheryl, et al.
Published: (2009-09-01)

Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: a cautionary tale
by: Lash Timothy L, et al.
Published: (2007-04-01)

Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression
by: Soldner, Frank, et al.
Published: (2017)

Behavioral and transcriptomic effects of the cancer treatment tamoxifen in mice
by: Elena Galvano, et al.
Published: (2023-02-01)

Cyclin-G-associated kinase modifies alpha-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study
by: Dumitriu, Alexandra, et al.
Published: (2011)

Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
by: Glen J. Weiss, et al.
Published: (2011-10-01)

Dynamic equilibration of airway smooth muscle length during physiological loading
by: Latourelle, Jeanne C. (Jeanne Catherine), 1976-
Published: (2014)

Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles
by: Adam Labadorf, et al.
Published: (2018-01-01)

Tamoxifen for women at high risk of breast cancer
by: Nazarali SA, et al.
Published: (2014-02-01)

Use of antipsychotics with tamoxifen
by: H. Ghabi, et al.
Published: (2021-04-01)

Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
by: Jeong-Ju Yoo, et al.
Published: (2020-01-01)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019-06-01)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019-06-01)

Tamoxifen in horses: pharmacokinetics and safety study
by: Gonzalo Gajardo, et al.
Published: (2019-06-01)

The endometrium in women receiving adjuvant tamoxifen therapy after surgical treatment of breast cance
by: E V Dmitrieva, et al.
Published: (2013-12-01)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
by: Ngoc Bao To, et al.
Published: (2022-09-01)

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.
by: Daniella Klebaner, et al.
Published: (2017-01-01)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
by: Yuntao Wang MS, et al.
Published: (2021-03-01)

Relation of hormones in ductal lavage fluid to age, tamoxifen treatment, and breast cancer risk
by: Chatterton RT, et al.
Published: (2009-07-01)

Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea
by: Dooreh Kim, et al.
Published: (2023-02-01)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
by: Emily K. Zboril, et al.
Published: (2023-06-01)

Research progress in tamoxifen in treatment of encapsulating peritoneal sclerosis
by: Kang Daxian, Sun Liping, Zhang Xinzhou
Published: (2024-01-01)

Tamoxifen Treatment for Riedel’s Thyroiditis: A Case Report
by: Ersen Karakılıç, et al.
Published: (2023-10-01)

The Use of Tamoxifen as a Potential Treatment for Bipolar Disorder
by: Noy Bagdadi, et al.
Published: (2021-09-01)

Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice.
by: Danilo C Miguel, et al.
Published: (2008-01-01)

Tamoxifen treatment adherence assessment by women with breast cancer
by: Caroline Oliveira Rangel, et al.
Published: (2020-01-01)

Tamoxifen and the singing voice.
by: Andrew Herxheimer
Published: (2005-09-01)

Tamoxifen- Induced Dermatomyositis
by: Bandyopadhyay Debabrata, et al.
Published: (1997-01-01)

Tamoxifen and ovarian function.
by: Martine Berliere, et al.
Published: (2013-01-01)

Tamoxifen and the singing voice.
Published: (2005-09-01)

Ocular toxicity of tamoxifen
by: Sekhar G, et al.
Published: (1995-01-01)

Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
by: Theodore J. Wigle, et al.
Published: (2017-12-01)

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
by: Fatemeh N. Emamzadeh, et al.
Published: (2018-08-01)

Tamoxifen Acts as a Parietal Cell Protonophore
by: E.H. Manning, et al.
Published: (2020-01-01)

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
by: Lundgren Steinar, et al.
Published: (2010-06-01)

Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer
by: Nupur Shrivastava, et al.
Published: (2022-07-01)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
by: Thomas Helland, et al.
Published: (2017-11-01)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
by: Seo Yun Moon, et al.
Published: (2021-08-01)

Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy
by: Cody Ramin, et al.
Published: (2023-03-01)

Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen.
by: Davies, C
Published: (2004)